Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Cash Flows

v3.26.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash Flows from Operating Activities:    
Net income (loss) $ 129,511 $ (27,518)
Reconciliation of net income (loss) to net cash used in operating activities:    
Depreciation expense 285 311
Bad debt expense (recovery) 78 (170)
Amortization of debt discount 1,752 1,065
Gain on termination of partner company lease   (394)
Loss on extinguishment of debt 1,009  
Amortization of acquired intangible assets 3,064 3,193
Settlement of partner company payables (109) (1,373)
Reduction in the carrying amount of operating lease right-of-use assets 1,274 1,467
Stock-based compensation expense 6,782 26,280
Change in fair value of investment (11,791) (15,075)
Change in fair value of partner company derivative liability 7,085  
Change in fair value of partner companies' warrant liabilities (1) 399
Issuance of subsidiary common shares for research and development expense 107  
Gain from deconsolidation of subsidiary (186) (27,127)
Increase (decrease) in cash and cash equivalents resulting from changes in operating assets and liabilities:    
Accounts receivable (17,682) (7,582)
Inventory 1,852 2,613
Other receivables - related party 104 29
Prepaid expenses and other current assets 2,258 4,099
Other assets (890) 309
Accounts payable and accrued expenses 9,611 (10,649)
Income taxes payable 4,763 73
Lease liabilities (1,425) (1,674)
Other current and long-term liabilities 926 (1,509)
Net cash provided by (used in) operating activities 138,377 (53,233)
Cash Flows from Investing Activities:    
Purchase of property and equipment (86)  
Proceeds from sale of property and equipment   1,165
Net cash increase upon deconsolidation of subsidiary   8,956
Net cash (used in) provided by investing activities (86) 10,121
Cash Flows from Financing Activities:    
Proceeds from issuance of common stock for at-the-market offering, net   1,008
Proceeds from issuance of common stock under ESPP 74 43
Exercise of warrants for cash 1,218 2,279
Proceeds from partner company's ESPP 223 217
Partner company's dividends declared and paid (23,199) (498)
Exchange of partner company preferred shares (165) (265)
Redemption of partner company preferred shares (14,170)  
Proceeds from partner companies' equity offerings and warrant exercises, net   61,581
Proceeds from partner companies' at-the-market offering, net (141) 13,631
Proceeds from exercise of partner company's options, net 275  
Repayment of Oaktree Note and debt issuance costs (29,601) (5,636)
Repayment of partner company installment payments - licenses   (625)
Net cash provided by (used in) financing activities (65,486) 71,735
Net increase in cash and cash equivalents and restricted cash 72,805 28,623
Cash and cash equivalents and restricted cash at beginning of period 80,601 58,815
Cash and cash equivalents and restricted cash at end of period 153,406 87,438
Supplemental disclosure of cash flow information:    
Cash paid for interest 4,937 5,678
Cash paid for income taxes $ 164 $ 49